Clinical trials
Completed Phase 2 Adenocarcinoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
95 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 1 |
| 2003 | 3 |
| 2004 | 2 |
| 2005 | 9 |
| 2006 | 5 |
| 2007 | 8 |
| 2008 | 6 |
| 2009 | 6 |
| 2010 | 7 |
| 2011 | 10 |
| 2012 | 4 |
| 2013 | 2 |
| 2014 | 2 |
| 2015 | 5 |
| 2016 | 2 |
| 2017 | 5 |
| 2018 | 5 |
| 2020 | 2 |
| 2021 | 6 |
| 2022 | 2 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 95 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 5 |
| UNICANCER | 4 |
| Eli Lilly and Company | 3 |
| Endocyte | 3 |
| Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 3 |
| University Health Network, Toronto | 3 |
| AIO-Studien-gGmbH | 2 |
| Clovis Oncology, Inc. | 2 |
| GlaxoSmithKline | 2 |
| M.D. Anderson Cancer Center | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Adenocarcinoma | 95 |
| Neoplasms | 21 |
| Neoplasm Metastasis | 16 |
| Pancreatic Neoplasms | 16 |
| Carcinoma, Non-Small-Cell Lung | 15 |
| Stomach Neoplasms | 12 |
| Lung Neoplasms | 10 |
| Carcinoma | 8 |
| Carcinoma, Squamous Cell | 8 |
| Esophageal Neoplasms | 8 |
Trials
Showing 1 to 25 of 95. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.